Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles, CA 90095-7370, USA.
Med Clin North Am. 2013 May;97(3):485-94. doi: 10.1016/j.mcna.2012.12.016. Epub 2013 Feb 1.
FDG-PET is a valuable tool that will continue to aid in identifying AD in its prodromal and early dementia stages, distinguishing it from other causes of dementia, and tracking progression of the disease. As brain FDG-PET scans and well-trained readers of these scans are becoming more widely available to clinicians who are becoming more informed about the role FDG-PET can play in early AD diagnosis, its use is expected to increase.
FDG-PET 是一种很有价值的工具，它将继续帮助识别前驱期和早期痴呆阶段的 AD，将其与其他痴呆原因区分开来，并跟踪疾病的进展。随着脑 FDG-PET 扫描以及对这些扫描有深入了解的读者越来越多，可供越来越了解 FDG-PET 在早期 AD 诊断中作用的临床医生使用，预计其使用将会增加。
Zotero 插件